$KERX KERYX BIOPHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in KERYX BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in KERYX BIOPHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in KERYX BIOPHARMACEUTICALS INC for free.
CIK Number: 0001114220
IRS Number: 134087132
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: KERX
Company Address: ONE MARINA PARK DR. BOSTON 02210
Market Capitalization: $574.30M
Prev close: $5.35
Average Daily Volume: 1,608,480
Days Low: $5.20
Year Low: $3.11
Year High: $7.80
KERYX BIOPHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Option Exercise | D | 0.00 | 140,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | ROGERS MICHAEL W | Director | Sell | D | 0.00 | 30,000 | 0 | 0 | 30 K to 0 (-100.00 %) |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Enyedy Mark J | Director | Option Exercise | D | 0.00 | 80,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Enyedy Mark J | Director | Sell | D | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Option Exercise | D | 0.00 | 902,500 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Holmes Scott A | Chief Financial Off ... | Sell | D | 0.00 | 162,956 | 0 | 0 | 163 K to 0 (-100.00 %) |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Option Exercise | D | 0.00 | 110,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Morrison Jodie Pope | Interim CEO | Sell | D | 0.00 | 120,000 | 0 | 0 | 120 K to 0 (-100.00 %) |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Option Exercise | D | 0.00 | 200,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Regan Daniel Paul | Director | Sell | D | 0.00 | 60,000 | 0 | 0 | 60 K to 0 (-100.00 %) |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Option Exercise | D | 0.00 | 110,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Heffernan Michael Thomas | Director | Sell | D | 0.00 | 20,000 | 0 | 0 | 20 K to 0 (-100.00 %) |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Option Exercise | D | 0.00 | 140,000 | 0 | 0 | |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | GILMAN STEVEN C | Director | Sell | D | 0.00 | 27,333 | 0 | 0 | 27.3 K to 0 (-100.00 %) |
Dec 13 2018 | KERX | KERYX BIOPHARMACEU ... | Neylan John F. | Chief Medical Offic ... | Option Exercise | D | 0.00 | 772,500 | 0 | 0 |